Delayed Release Pancreatin Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,198,871 | Delayed Release Pancreatin Compositions In force · High confidence UsedRemaining | Abbott Products GmbH | In force | High confidence | ||
| Application 14/074,255 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned Jun 27, 2014 | Abbott Products GmbH | Abandoned | Abandoned Jun 27, 2014 | ||
| Application 14/882,385 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned May 25, 2016 | Abbott Products GmbH | Abandoned | Abandoned May 25, 2016 | ||
| Application 15/163,445 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned May 22, 2019 | Abbott Products GmbH | Abandoned | Abandoned May 22, 2019 | ||
| Application 16/395,857 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned Dec 7, 2020 | Abbott Products GmbH | Abandoned | Abandoned Dec 7, 2020 | ||
| Application 17/095,985 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned Jun 24, 2021 | Abbott Products GmbH | Abandoned | Abandoned Jun 24, 2021 | ||
| Application 17/304,562 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned Jun 26, 2023 | AbbVie Pharmaceuticals GmbH | Abandoned | Abandoned Jun 26, 2023 | ||
| Application 18/338,030 | Controlled Release Pharmaceutical Compositions for Acid-Labile Drugs Abandoned Abandoned Apr 6, 2026 | AbbVie Pharmaceuticals GmbH | Abandoned | Abandoned Apr 6, 2026 |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Abbott Products GmbH.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.